Dr. Pablo Lores Lareo, PhD

CMC Director at Sylentis

Speaker

Pablo Lores Lareo is CMC Director at Sylentis, a CDMO specialized in the development and GMP manufacturing of therapeutic oligonucleotide APIs.

Pablo has designed and led development programs from early-stage concept through to commercialization for several oligonucleotide drug candidates, authoring IND and IMPD submissions, and overseeing the execution through key regulatory, technical, and operational milestones. His work spans analytical development, process characterization, manufacturing readiness, and regulatory alignment across multiple oligonucleotide modalities.

He is particularly focused on building phase-appropriate, risk-based CMC strategies that reflect the operational realities of small biotech organizations, where precision of decision-making and resource efficiency matter as much as technical rigor.